Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Il-38 As an Early Predictor of the Ischemic Stroke Prognosis Publisher Pubmed



Zare Rafie M1 ; Esmaeilzadeh A2 ; Ghoreishi A3 ; Tahmasebi S4 ; Faghihzadeh E5 ; Elahi R1
Authors

Source: Cytokine Published:2021


Abstract

Background: Ischemic stroke is caused by a sudden neurological defect following a vascular occlusion and elicits a local and systemic inflammation in brain tissue. Interleukin-38 is an anti-inflammatory cytokine associated with ischemic and inflammatory diseases. This study was designed to analyze the effect of tPA therapy on interleukin-38 serum level changes and the serum level of IL-38 in the prognosis of ischemic stroke patients in the next three months. Methods: We enrolled 29 ischemic stroke patients confirmed by a neurologist based on radiologic and clinical manifestation between 2019 September to 2020 February. The patients who had NIHSS more than 6 with no underlying inflammatory diseases were selected for tPA therapy. On admission and 24 h after tPA therapy, the IL-38 serum level was measured by ELISA kit. Results: The results showed that serum levels of IL-38 were significantly increased after tPA therapy (P < 0.001). A remarkable relationship was observed between the modified Rankin Score (mRS) and IL-38 serum changes in response to tPA therapy (P < 0.001). Besides, IL-38 serum changes following tPA were dramatically related to NIHSS at hospitalization (P = 0.007). Also, our analysis posed a positive relation between NIHSS at hospitalization and mRs criteria (P = 0.023). No notable relation has been observed between IL-38 serum levels before and after tPA and mRs (P = 0.601 and P = 0.074, respectively). Furthermore, there was no evidence for the relation between NIHSS at hospitalization and IL-38 levels before and after tPA (P = 0.457 and P = 0.105, respectively). Conclusion: The results indicate that tPA could meaningfully increase the IL-38 serum level. Also, a negative correlation has been found between IL-38 serum changes in response to tPA and mRS. Since the lower changes in IL-38 serum level result in a poorer prognosis, we conclude that IL-38 serum changes might be a novel early predictor factor for ischemic stroke prognosis. © 2021
Related Docs
View other Related Docs
1. The Role of Endothelial Progenitor Cells in Transient Ischemic Attack Patients for Future Cerebrovascular Events, Journal of Research in Medical Sciences (2016)
2. Whey Protein Plus Lipoic Acid Supplementation Improves Inflammatory and Antioxidant Markers of Patients With Acute Ischemic Stroke: A Double-Blind, Randomized Controlled Clinical Trial, Nutrition and Food Science (2020)
3. Two Ischemic Stroke Events Within 48 H: A Case Report of an Unusual Presentation of Thrombotic Thrombocytopenic Purpura, BMC Neurology (2023)
Experts (# of related papers)
View all Related Experts
Mostafa Hosseini (2)
Mojdeh Ghabaee (1)
Other Related Docs
4. Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke Following Cardiac Interventions: A Systematic Review and Meta-Analysis, CardioVascular and Interventional Radiology (2025)
5. Safety and Efficacy of Intravenous Thrombolytic Therapy in the Extended Window up to 24 Hours: A Systematic Review and Meta-Analysis, Annals of Clinical and Translational Neurology (2024)
6. The Safety and Efficacy of Neva Mechanical Thrombectomy Device in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2024)
7. Neuroprotective Effects of N-Acetyl-Cysteine in Patients With Acute Ischemic Stroke: A Randomized Controlled Trial, Current Drug Therapy (2025)
8. Risk of Stroke After Traumatic Brain Injury: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2025)
9. The Relationship Between Serum Concentrations of Pro- and Anti-Inflammatory Cytokines and Nutritional Status in Patients With Traumatic Head Injury in the Intensive Care Unit, Medicina (Lithuania) (2019)
10. Interleukin-1 Beta, Interferon-Gamma, and Tumor Necrosis Factor-Alpha Gene Expression in Peripheral Blood Mononuclear Cells of Patients With Coronary Artery Disease, ARYA Atherosclerosis (2015)
11. Safety of Current Therapies for Cardiogenic Cerebral Embolism: A Systematic Review, Journal of Endovascular Resuscitation and Trauma Management (2025)
12. Cytokines and Chemokines Profile in Encephalitis Patients: A Meta-Analysis, PLoS ONE (2022)
13. Functional Improvement and Immune-Inflammatory Cytokines Profile of Ischaemic Stroke Patients After Treatment With Boswellic Acids: A Randomized, Double-Blind, Placebo-Controlled, Pilot Trial, Inflammopharmacology (2019)
14. Regulation of Dapk1 by Natural Products: An Important Target in Treatment of Stroke, Neurochemical Research (2022)
15. Association of Changed Serum Brain Biomarkers With Perihematomal Edema and Early Clinical Outcome in Primary Ich Patients, Neurologist (2022)
16. Evaluation of De Ritis (Ast/Alt), Alp/Alt, and Ast/Alp Ratios As Prognostic Factors in Patients With Acute Ischemic Stroke, BMC Neurology (2022)
17. Safety of Intravenous Thrombolysis Among Stroke Patients Taking New Oral Anticoagulants - Case Series and Systematic Review of Reported Cases, Journal of Stroke and Cerebrovascular Diseases (2015)
18. A Multicenter Diagnostic Accuracy Study on Prehospital Stroke Screening Scales, Archives of Iranian Medicine (2021)
19. Serum Igf-1 Level As a Prognostic Marker for Acute Ischemic Stroke: A Systematic Review, Frontiers in Emergency Medicine (2025)
20. Investigation the Frequency of Asymptomatic Hemorrhagic Transformation of Infarction in Ct Scan of Acute Ischemic Stroke Patients, Tehran University Medical Journal (2019)